ARG Improves Clinical Trial Performance with Vault CTMS

September 12, 2018

Greater visibility, proactive trial management, and better study analytics and reporting are top drivers for clinical operations professionals to improve the use of CTMS. This is a viewpoint shared by Hunter Walker, chief technology officer at ARG.

Please check out the recent Veeva blog post featuring Hunter as he prepares to travel to Philadelphia for their 2018 Summit.

Previous Next

ARG’s Environment Of Support & Success: 20 Years Of Impact

Making an impact looks different for any business, especially for the variety of Contract Research Organizations (CROs) in the world. […]

May 2, 2024

The Vital Role of Team Stability in Advancing Clinical Trials

In the fast-paced world of clinical research, turnover rates are high and project continuity can be a challenge. However, at […]

March 29, 2024

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024